Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers

Peter Horak, Christoph Heining, Simon Kreutzfeldt, +55

Cancer Discovery

The landscape of chromothripsis across adult cancer types

Natalia Voronina, John Wong, Daniel Hübschmann, +26

Nature Communications

Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers

Arne Jahn, Andreas Rump, Thomas J. Widmann, +74

Annals of Oncology

<scp>ZBTB</scp> 48 is both a vertebrate telomere‐binding protein and a transcriptional activator

Arne Jahn, Grishma Rane, Maciej Paszkowski‐Rogacz, +8

EMBO Reports

Diagnostic value of partial exome sequencing in developmental disorders

Laura Gieldon, Luisa Mackenroth, Anne‐Karin Kahlert, +17

PLoS ONE

BioinformaticsDevelopmental AnomalyMendelian DisorderPsychiatryPartial Exome Sequencing +11

Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity

Lino Möhrmann, Maximilian Werner, Małgorzata Oleś, +41

Nature Communications

Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome

Linda A.J. Hendricks, Nicoline Hoogerbrugge, Arjen R. Mensenkamp, +29

JNCI Journal of the National Cancer Institute

Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research Approaches

Laura Gieldon, Doreen William, Karl Hackmann, +20

Cancers

NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology

Andreas Möck, Maria‐Veronica Teleanu, Simon Kreutzfeldt, +29

npj Precision Oncology

Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohort

Linda A.J. Hendricks, Nicoline Hoogerbrugge, Hanka Venselaar, +25

European Journal of Medical Genetics